Jessica Fung
Stock Analyst at JP Morgan
(0.75)
# 2,873
Out of 4,479 analysts
5
Total ratings
50%
Success rate
-8.61%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Neutral | $150 → $170 | $247.61 | -31.34% | 2 | Feb 1, 2024 | |
| UTHR United Therapeutics | Maintains: Overweight | $290 → $294 | $317.05 | -7.27% | 2 | Nov 2, 2023 | |
| FSM Fortuna Silver Mines | Upgrades: Outperform | n/a | $4.95 | - | 1 | Mar 31, 2017 |
Alnylam Pharmaceuticals
Feb 1, 2024
Maintains: Neutral
Price Target: $150 → $170
Current: $247.61
Upside: -31.34%
United Therapeutics
Nov 2, 2023
Maintains: Overweight
Price Target: $290 → $294
Current: $317.05
Upside: -7.27%
Fortuna Silver Mines
Mar 31, 2017
Upgrades: Outperform
Price Target: n/a
Current: $4.95
Upside: -